Bausch Health Cos Income Taxes 2010-2024 | BHC

Bausch Health Cos income taxes from 2010 to 2024. Income taxes can be defined as the total amount of income tax expense for the given period.
Bausch Health Cos Annual Income Taxes
(Millions of US $)
2023 $221
2022 $83
2021 $-87
2020 $-375
2019 $-54
2018 $-10
2017 $-4,145
2016 $-27
2015 $133
2014 $174
2013 $-451
2012 $-278
2011 $-178
2010 $-28
2009 $-2
Bausch Health Cos Quarterly Income Taxes
(Millions of US $)
2024-06-30 $49
2024-03-31 $8
2023-12-31 $40
2023-09-30 $56
2023-06-30 $52
2023-03-31 $73
2022-12-31 $53
2022-09-30 $36
2022-06-30 $10
2022-03-31 $-16
2021-12-31 $-51
2021-09-30 $25
2021-06-30 $-77
2021-03-31 $16
2020-12-31 $-242
2020-09-30 $5
2020-06-30 $-112
2020-03-31 $-26
2019-12-31 $47
2019-09-30 $-18
2019-06-30 $-9
2019-03-31 $-74
2018-12-31 $-84
2018-09-30 $51
2018-06-30 $138
2018-03-31 $-115
2017-12-31 $-1,316
2017-09-30 $-1,700
2017-06-30 $-205
2017-03-31 $-924
2016-12-31 $152
2016-09-30 $-113
2016-06-30 $-73
2016-03-31 $7
2015-12-31 $119
2015-09-30 $-57
2015-06-30 $-13
2015-03-31 $85
2014-12-31 $50
2014-09-30 $100
2014-06-30 $-1
2014-03-31 $25
2013-12-31 $-203
2013-09-30 $-169
2013-06-30 $-51
2013-03-31 $-27
2012-12-31 $-185
2012-09-30 $-97
2012-06-30 $5
2012-03-31 $-0
2011-12-31 $-133
2011-09-30 $-29
2011-06-30 $-13
2011-03-31 $-3
2010-12-31 $-103
2010-09-30 $60
2010-06-30 $5
2010-03-31 $9
2009-12-31 $-25
2009-09-30 $8
2009-06-30 $4
2009-03-31 $12
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $2.956B $8.757B
Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $20.120B 6.83
Dr Reddy's Laboratories (RDY) India $13.079B 19.59
BridgeBio Pharma (BBIO) United States $5.045B 0.00
Amphastar Pharmaceuticals (AMPH) United States $2.438B 13.65
Supernus Pharmaceuticals (SUPN) United States $1.771B 357.00
Taysha Gene Therapies (TSHA) United States $0.449B 73.00
Personalis (PSNL) United States $0.315B 0.00
Assembly Biosciences (ASMB) United States $0.117B 0.00
Acasti Pharma (ACST) Canada $0.028B 0.00
Sol-Gel Technologies (SLGL) Israel $0.020B 0.00
Evoke Pharma (EVOK) United States $0.004B 0.00
Teligent (TLGT) United States $0.000B 0.00